Tradestie Institutional Equity Comparison Engine

PLUR vs OVID โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OVID Overall Edge

OVID Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ovid Therapeutics Inc. Common Stock (OVID) driven by superior Valuation, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Growth & Margin. Fundamentally, PLUR trades at 3.6x Forward P/E with -2454.5% operating margin (-15.8% YoY revenue) versus OVID at 1.8x Forward P/E and -4693.7% operating margin (-88.3% YoY). In options structure, PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OVID sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OVID
PLUR 3.6x vs OVID 1.8x Fwd P/E
Growth & Margin Winner PLUR
Op Margin -2454.5% vs -4693.7% ยท YoY -15.8% vs -88.3%
Momentum & Technical Winner OVID
1Y -78.8% vs +68.2% ยท 52W Pos 2% vs 53%
Options & Structure Winner OVID
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (30th %ile IV)
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.94
-9.19% 1D
Market Cap $15.1M
1M Return +11.09%
1Y Return -78.78%
Forward P/E 3.6x
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0
OVID NASDAQ
Ovid Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.19
-8.54% 1D
Market Cap $479.4M
1M Return +1.15%
1Y Return +68.2%
Forward P/E 1.8x
Unified AI Score
52.3 / 100 HOLD
Tech 29.0 Fund 48.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PLUR -78.78% OVID +68.2% Spread: +143.73 pp (OVID Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PLUR Revenue OVID Revenue PLUR Op. Margin OVID Op. Margin Margin Edge
FY2019 $0M N/A -65800.0% N/A PLUR
FY2020 $0M $10M -128156.5% -645.4% OVID
FY2021 N/A $210M N/A 59.6% OVID
FY2022 $0M $0M -17774.8% -3696.4% OVID
FY2023 $0M $0M -9493.4% -15122.7% PLUR
FY2024 $0M $0M -6796.9% -10933.7% PLUR
FY2025 $0M $10M -1659.9% -585.2% OVID
FY2026 $0M N/A -2454.5% N/A PLUR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PLUR (2) vs OVID (7)
Institutional Metric PLUR OVID Criterion Row Winner
Market Capitalization Scale $15.1M $479.4M Larger Scale OVID
Trailing P/E Ratio Valuation 3.6x 1.8x Lower Multiple OVID
Forward P/E Ratio Valuation 3.6x 1.8x Lower Multiple OVID
Revenue Growth (YoY) Growth -15.8% -88.3% Higher Growth PLUR
Operating Margin (TTM) Profitability -2454.5% -4693.7% Higher Margin PLUR
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1022.0% -35.4% Higher ROE OVID
52-Week Range Position Momentum 2% ($1โ€“$5) 53% ($1โ€“$3) Stronger Trend OVID
Beta / 30D Volatility Risk Regime 0.80ฮฒ ยท 102% Vol 1.06ฮฒ ยท 99% Vol Lower Realized Risk OVID
Unified Institutional Score Composite Signal 28.8 / 100 (SELL) 52.3 / 100 (HOLD) Higher Composite OVID

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PLUR vs OVID Buy Guide
PLUR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OVID CONSOLIDATION
151d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OVID Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PLUR nor OVID registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.